SG Americas Securities
KRON

SG Americas Securities’s Kronos Bio KRON Stock Holding History

SG Americas Securities’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-17,532
Closed -$26K – 2746
2023
Q1 		$26K Buy
17,532
+4,343
+33% +$8.33K ﹤0.01% 3132
2022
Q4 		$21K Sell
13,189
-127,926
-91% -$294K ﹤0.01% 2929
2022
Q3 		$473K Sell
141,115
-7,099
-5% -$32K 0.01% 1597
2022
Q2 		$539K Buy
148,214
+21,369
+17% +$96.9K 0.01% 1898
2022
Q1 		$917K Sell
126,845
-59,279
-32% -$505K 0.01% 1485
2021
Q4 		$2.53M Buy
186,124
+162,763
+697% +$2.55M 0.01% 914
2021
Q3 		$490K Buy
+23,361
New +$502K ﹤0.01% 2522

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SG Americas Securities's KRON Position: Q2 2023 in Review

SG Americas Securities sold out of Kronos Bio (KRON) in Q2 2023, closing a stake of 17,532 shares — an estimated $26K sold.

SG Americas Securities first reported a position in KRON in Q3 2021 and held it in 7 quarters. The position peaked at $2.53M in Q4 2021. 80 funds tracked by Wall St. Rank hold KRON as of Q2 2023.

  • SG Americas Securities reported no remaining Kronos Bio position as of Q2 2023 after selling out during the quarter.
  • SG Americas Securities sold 17,532 Kronos Bio shares in Q2 2023, an estimated $26K.
  • SG Americas Securities first reported a position in Kronos Bio in Q3 2021 and held it in 7 quarters.
  • SG Americas Securities's Kronos Bio position peaked at $2.53M in Q4 2021.
  • 80 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2023.

Based on SG Americas Securities's 13F filing for Q2 2023, filed 10 Jul 2023.